New analysis exhibits outcomes are worse for Black sufferers with acute myeloid leukemia (AML) than white sufferers who obtained related intensive remedy on scientific trials.
New analysis exhibits outcomes are worse for Black sufferers with acute myeloid leukemia (AML) than white sufferers who obtained related intensive remedy on scientific trials.